DexCom, Inc.
DE ˙ DB ˙ US2521311074
€ 62,20 ↓ -0.20 (-0.32%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:DC4 / DexCom, Inc.
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership42,403 shares
Latest Disclosed Value $ 2,662,905
Captrust Financial Advisors reports 2.35% increase in ownership of DC4 / DexCom, Inc.

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 42,403 shares of DexCom, Inc. (DE:DC4) valued at $2,297,819 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 41,431 shares of DexCom, Inc.. This represents a change in shares of 2.35% during the quarter. The current value of the position is $2,637,467 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F DEXCOM INC COM Stock 252131107 42,403 972 2.35 2,663 -3.16 0.0046
2026-02-17 2025-12-31 13F DEXCOM INC COM Stock 252131107 41,431 13,913 50.56 2,750 48.51 0.0052
2025-11-19 2025-09-30 13F DEXCOM INC COM Stock 252131107 27,518 -5,717 -17.20 1,852 -36.19 0.0038
2025-08-15 2025-06-30 13F DEXCOM INC COM Stock 252131107 33,235 3,661 12.38 2,901 43.68 0.0065
2025-05-15 2025-03-31 13F DEXCOM INC COM Stock 252131107 29,574 1,422 5.05 2,020 -7.77 0.0051
2025-02-14 2024-12-31 13F DEXCOM INC COM Stock 252131107 28,152 5,101 22.13 2,189 41.68 0.0063
2024-11-14 2024-09-30 13F DEXCOM INC COM Stock 252131107 23,051 1,022 4.64 1,545 -38.13 0.0046
2024-08-15 2024-06-30 13F DEXCOM INC COM Stock 252131107 22,029 -247 -1.11 2,498 -19.16 0.0080
2024-05-15 2024-03-31 13F DEXCOM INC COM Stock 252131107 22,276 -22,084 -49.78 3,090 -43.88 0.0114
2024-02-14 2023-12-31 13F DEXCOM INC COM Stock 252131107 44,360 6,781 18.04 5,505 56.99 0.0190
2023-11-15 2023-09-30 13F DEXCOM INC COM Stock 252131107 37,579 10,664 39.62 3,506 1.39 0.0134
2023-08-15 2023-06-30 13F DEXCOM INC COM Stock 252131107 26,915 7,166 36.29 3,459 50.74 0.0136
2023-05-15 2023-03-31 13F DEXCOM INC COM Stock 252131107 19,749 -356 -1.77 2,294 0.79 0.0101
2023-02-15 2022-12-31 13F DEXCOM INC COM Stock 252131107 20,105 1,091 5.74 2,277 48.66 0.0115
2022-11-16 2022-09-30 13F DEXCOM INC COM ADR 252131107 19,014 4,205 28.39 1,531 38.68 0.0089
2022-08-23 2022-06-30 13F/A-1 DEXCOM INC COM Common Stock 252131107 14,809 10,616 253.18 1,104 -48.53 0.0071
2022-08-16 2022-06-30 13F DEXCOM INC COM COM 252131107 16,376 12,183 1,221 0.0089
2022-05-16 2022-03-31 13F DEXCOM COM 252131107 4,193 1,002 31.40 2,145 25.22 0.0139
2022-02-14 2021-12-31 13F DEXCOM INC COM Common Stock 252131107 3,191 132 4.32 1,713 2.39 0.0117
2021-11-16 2021-09-30 13F DEXCOM INC COM Common Stock 252131107 3,059 -820 -21.14 1,673 1.03 0.0139
2021-08-16 2021-06-30 13F DEXCOM INC COM Common Stock 252131107 3,879 -361 -8.51 1,656 8.66 0.0154
2021-05-17 2021-03-31 13F DEXCOM INC COM Common Stock 252131107 4,240 2,217 109.59 1,524 103.74 0.0165
2021-02-16 2020-12-31 13F DEXCOM INC COM Common Stock 252131107 2,023 223 12.39 748 0.40 0.0099
2020-11-17 2020-09-30 13F DEXCOM INC COM Common Stock 252131107 1,800 217 13.71 745 17.51 0.0124
2020-08-14 2020-06-30 13F DEXCOM INC COM Common Stock 252131107 1,583 199 14.38 634 79.60 0.0104
2020-05-15 2020-03-31 13F DEXCOM INC COM Common Stock 252131107 1,384 -51 -3.55 353 12.06 0.0078
2020-02-14 2019-12-31 13F DEXCOM COM 252131107 1,435 1,364 1,921.13 315 2,763.64 0.0050
2019-11-14 2019-09-30 13F DEXCOM INC COM Common Stock 252131107 71 0 0.00 11 0.00 0.0004
2019-08-13 2019-06-30 13F DEXCOM INC COM Common Stock 252131107 71 46 184.00 11 266.67 0.0004
2019-05-15 2019-03-31 13F DEXCOM INC COM Common Stock 252131107 25 0 0.00 3 0.00 0.0001
2019-02-13 2018-12-31 13F DEXCOM INC COM Common Stock 252131107 25 0 0.00 3 -25.00 0.0002
2018-11-15 2018-09-30 13F DEXCOM INC COM Common Stock 252131107 25 0 0.00 4 100.00 0.0002
2018-08-13 2018-06-30 13F DEXCOM INC COM Common Stock 252131107 25 0 0.00 2 0.00 0.0001
2018-05-15 2018-03-31 13F DEXCOM INC COM Common Stock 252131107 25 0 0.00 2 100.00 0.0001
2018-02-14 2017-12-31 13F DEXCOM INC COM Common Stock 252131107 25 25 0.00 1 -50.00 0.0001
2017-11-13 2017-09-30 13F DEXCOM INC COM Common Stock 252131107 0 -25 -100.00 0 -100.00
2017-08-10 2017-06-30 13F DEXCOM INC COM Common Stock 252131107 25 25 2 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.